PURPOSE: To prospectively determine reproducibility of magnetic resonance (MR) angiography and MR spectroscopy of deoxymyoglobin in assessment of collateral vessels and tissue perfusion in patients with critical limb ischemia (CLI) and to follow changes in patients undergoing intramuscular vascular endothelial growth factor (pVEGF)-C gene therapy, percutaneous transluminal angioplasty, supervised exercise training, or no therapy. MATERIALS AND METHODS: Study and gene therapy protocols were approved, and all patients gave written informed consent. To determine repeatability and reproducibility, seven patients underwent MR angiography and five underwent MR spectroscopy. The techniques were used to judge disease progress in 12 other patients with or without therapy: MR angiography to help determine change in visualization of collateral vessels and MR spectroscopy to help assess change in perfusion at proximal and distal calf levels. MR angiographic results were subjectively analyzed by three blinded readers. Intraobserver variability was expressed as 95% confidence interval (CI) (n=7); interobserver variability, as kappa statistic (n=15). Reexamination variability of MR spectroscopy was given as 95% CI for subsequent recovery times, and correlation with disease extent was calculated with Kendall taub rank correlation. Fisher-Yates test was used to correlate changes with pressure measurements and clinical course. RESULTS: Intraobserver and interobserver concordance was sensitive for detection of collateral vessels. Intraobserver agreement was 85.7% (95% CI: 42.1%, 99.6%). Interobserver agreement was high for small collateral vessels (kappa=0.74, P <.001) and fair for large collateral vessels (kappa=0.36, P=.002). MR spectroscopy was reproducible (95% CI: +/-26 seconds for proximal, +/-21 seconds for distal) and showed a correlation with disease extent (proximal calf, taub=0.84, P <.001; distal calf, taub=0.68, P=.04). Small collateral vessels increased over time (P=.04) but did not correlate with pressure measurements and clinical course. Recovery time correlated with clinical course (proximal calf, P=.03; distal calf, P=.005). CONCLUSION: MR angiography and MR spectroscopy of deoxymyoglobin can help document changes in visualization of collateral vessels and tissue perfusion in patients with CLI.
PURPOSE: To prospectively determine reproducibility of magnetic resonance (MR) angiography and MR spectroscopy of deoxymyoglobin in assessment of collateral vessels and tissue perfusion in patients with critical limb ischemia (CLI) and to follow changes in patients undergoing intramuscular vascular endothelial growth factor (pVEGF)-C gene therapy, percutaneous transluminal angioplasty, supervised exercise training, or no therapy. MATERIALS AND METHODS: Study and gene therapy protocols were approved, and all patients gave written informed consent. To determine repeatability and reproducibility, seven patients underwent MR angiography and five underwent MR spectroscopy. The techniques were used to judge disease progress in 12 other patients with or without therapy: MR angiography to help determine change in visualization of collateral vessels and MR spectroscopy to help assess change in perfusion at proximal and distal calf levels. MR angiographic results were subjectively analyzed by three blinded readers. Intraobserver variability was expressed as 95% confidence interval (CI) (n=7); interobserver variability, as kappa statistic (n=15). Reexamination variability of MR spectroscopy was given as 95% CI for subsequent recovery times, and correlation with disease extent was calculated with Kendall taub rank correlation. Fisher-Yates test was used to correlate changes with pressure measurements and clinical course. RESULTS: Intraobserver and interobserver concordance was sensitive for detection of collateral vessels. Intraobserver agreement was 85.7% (95% CI: 42.1%, 99.6%). Interobserver agreement was high for small collateral vessels (kappa=0.74, P <.001) and fair for large collateral vessels (kappa=0.36, P=.002). MR spectroscopy was reproducible (95% CI: +/-26 seconds for proximal, +/-21 seconds for distal) and showed a correlation with disease extent (proximal calf, taub=0.84, P <.001; distal calf, taub=0.68, P=.04). Small collateral vessels increased over time (P=.04) but did not correlate with pressure measurements and clinical course. Recovery time correlated with clinical course (proximal calf, P=.03; distal calf, P=.005). CONCLUSION: MR angiography and MR spectroscopy of deoxymyoglobin can help document changes in visualization of collateral vessels and tissue perfusion in patients with CLI.
Authors: Aoife N Keeling; Timothy J Carroll; Mary M McDermott; Kiang Liu; Yihua Liao; Cormac T Farrelly; William H Pearce; James Carr Journal: Vasc Med Date: 2012-06-27 Impact factor: 3.239
Authors: Mary M McDermott; James Carr; Kiang Liu; Christopher M Kramer; Chun Yuan; Lu Tian; Michael H Criqui; Jack M Guralnik; Luigi Ferrucci; Lihui Zhao; Dongxiang Xu; Melina Kibbe; Jarett Berry; Timothy J Carroll Journal: Vasc Med Date: 2014-07-21 Impact factor: 3.239
Authors: Justin D Anderson; Frederick H Epstein; Craig H Meyer; Klaus D Hagspiel; Hongkun Wang; Stuart S Berr; Nancy L Harthun; Arthur Weltman; Joseph M Dimaria; Amy M West; Christopher M Kramer Journal: J Am Coll Cardiol Date: 2009-08-11 Impact factor: 24.094
Authors: Mary M McDermott; Timothy J Carroll; Melina Kibbe; Christopher M Kramer; Kiang Liu; Jack M Guralnik; Aoife N Keeling; Michael H Criqui; Luigi Ferrucci; Chun Yuan; Lu Tian; Yihua Liao; Jarett Berry; Lihui Zhao; James Carr Journal: JACC Cardiovasc Imaging Date: 2013-05-04
Authors: Mary M McDermott; Timothy Carroll; James Carr; Chun Yuan; Luigi Ferrucci; Jack M Guralnik; Melina Kibbe; Michael H Criqui; Lu Tian; Tamar Polonsky; Lihui Zhao; Ying Gao; Daniel S Hippe; Dongxiang Xu; Walter McCarthy; Christopher M Kramer Journal: Vasc Med Date: 2017-09-30 Impact factor: 3.239
Authors: Karolien Jaspers; Bas Versluis; Tim Leiner; Petra Dijkstra; Marlies Oostendorp; Jolanda M van Golde; Mark J Post; Walter H Backes Journal: PLoS One Date: 2011-01-26 Impact factor: 3.240
Authors: Dominik P Guensch; Matthias C Michel; Stefan P Huettenmoser; Bernd Jung; Patrik Gulac; Adrian Segiser; Sarah L Longnus; Kady Fischer Journal: Sci Rep Date: 2021-06-01 Impact factor: 4.379